CLINICAL_TRIALS
trial_result
· 2016-03-09
Clinical Trial Update: Study to Evaluate the Effects of MBX-8025 in Patients With HoFH [Phase 2]
Summary
Phase 2 clinical trial update evaluating MBX-8025 in patients with Homozygous Familial Hypercholesterolemia; the study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: Homozygous Familial Hypercholesterolemia | Phase 2 | Status: COMPLETED